$696 Million is the total value of Rhenman & Partners Asset Management AB's 108 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 15.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Buy | Horizon Pharma Plc | $28,750,000 | +11.1% | 2,422,090 | +38.3% | 4.13% | +0.7% |
| EXEL | Buy | Exelixis Inc | $25,862,000 | +89.4% | 1,050,000 | +66.7% | 3.71% | +71.7% |
| NVCR | New | NovoCure Ltd Reg | $21,042,000 | – | 1,216,314 | +100.0% | 3.02% | – |
| ALXN | Buy | Alexion Pharmaceuticals Inc | $18,737,000 | +38.4% | 154,000 | +37.9% | 2.69% | +25.4% |
| CELG | Buy | Celgene Corp | $18,442,000 | +59.4% | 142,000 | +52.7% | 2.65% | +44.5% |
| GILD | Buy | Gilead Sciences Inc | $18,185,000 | +29.4% | 256,916 | +24.2% | 2.61% | +17.3% |
| INCY | Buy | Incyte Corp Ltd | $17,633,000 | +14.7% | 140,046 | +21.8% | 2.53% | +4.0% |
| BMRN | Buy | BioMarin Pharmaceutical Inc | $17,192,000 | +56.7% | 189,300 | +51.4% | 2.47% | +42.0% |
| MDT | Buy | Medtronic Plc | $16,961,000 | +16.2% | 191,115 | +5.5% | 2.44% | +5.4% |
| ESPR | Sell | Esperion Therapeutics Inc | $16,816,000 | -12.4% | 363,347 | -33.1% | 2.41% | -20.5% |
| UNH | Buy | United Health Group Inc | $16,688,000 | +56.5% | 90,000 | +38.5% | 2.40% | +41.9% |
| NKTR | Buy | Nektar Therapeutics | $15,542,000 | +40.9% | 795,000 | +69.1% | 2.23% | +27.8% |
| ABMD | Sell | Abiomed Inc | $15,211,000 | +3.8% | 106,150 | -9.3% | 2.18% | -5.9% |
| PFE | Buy | Pfizer Inc | $14,458,000 | +26.0% | 430,422 | +28.3% | 2.08% | +14.3% |
| GKOS | Buy | Glaukos Corp | $14,326,000 | -14.3% | 345,450 | +6.0% | 2.06% | -22.3% |
| New | NeuroDerm Ltd | $13,803,000 | – | 461,654 | +100.0% | 1.98% | – | |
| JAZZ | Buy | Jazz Pharmaceuticals Plc | $13,221,000 | +51.0% | 85,020 | +40.9% | 1.90% | +36.9% |
| BIIB | Sell | Biogen Inc | $13,161,000 | -29.2% | 48,500 | -28.7% | 1.89% | -35.8% |
| AGN | Sell | Allergan Plc | $12,641,000 | -10.3% | 52,000 | -11.9% | 1.82% | -18.7% |
| LLY | Sell | Eli Lilly & Co | $12,345,000 | -13.7% | 150,000 | -11.8% | 1.77% | -21.7% |
| VRTX | Vertex Pharmaceuticals Inc | $12,244,000 | +17.8% | 95,013 | 0.0% | 1.76% | +6.9% | |
| ZBH | Buy | Zimmer Biomet Hgs Inc | $11,556,000 | +35.2% | 90,000 | +28.6% | 1.66% | +22.5% |
| NVRO | Buy | Nevro Corp | $11,545,000 | +9.4% | 155,118 | +37.7% | 1.66% | -0.8% |
| ITCI | Buy | Intra-Cellular Therapies Inc | $10,348,000 | -11.0% | 833,154 | +16.4% | 1.49% | -19.3% |
| ESRX | Buy | Express Scripts Hg Co | $9,959,000 | +57.4% | 156,000 | +62.5% | 1.43% | +42.7% |
| ABBV | Buy | AbbVie Inc | $9,789,000 | +15.6% | 135,000 | +3.8% | 1.41% | +4.8% |
| MRK | Sell | Merck & Co Inc | $8,973,000 | -11.7% | 140,000 | -12.5% | 1.29% | -20.0% |
| HUM | Buy | Humana Inc | $8,422,000 | +27.7% | 35,000 | +9.4% | 1.21% | +15.7% |
| HCA | Sell | HCA Healthcare Inc | $8,258,000 | -11.4% | 94,707 | -9.6% | 1.19% | -19.6% |
| CNC | Buy | Centene Corp | $7,988,000 | +28.0% | 100,000 | +14.2% | 1.15% | +16.1% |
| ALKS | Sell | Alkermes Plc | $7,850,000 | -4.4% | 135,409 | -3.6% | 1.13% | -13.4% |
| WBA | Buy | Walgreens Boots Alliance Inc | $7,831,000 | +109.6% | 100,000 | +122.2% | 1.12% | +89.9% |
| SNY | New | Sanofi spons ADR repr 0.5 Share | $7,666,000 | – | 160,000 | +100.0% | 1.10% | – |
| ELGX | Sell | Endologix Inc | $7,655,000 | -33.9% | 1,575,000 | -1.6% | 1.10% | -40.1% |
| DXCM | Buy | Dexcom Inc | $7,635,000 | +58.4% | 104,380 | +83.4% | 1.10% | +43.6% |
| CI | Sell | Cigna Corp | $7,533,000 | -19.6% | 45,000 | -29.7% | 1.08% | -27.1% |
| REGN | Sell | Regeneron Pharmaceuticals Inc | $7,416,000 | -48.3% | 15,100 | -59.2% | 1.06% | -53.1% |
| CVS | Sell | CVS Health Corp | $6,839,000 | -33.0% | 85,000 | -34.6% | 0.98% | -39.2% |
| ADMS | Buy | Adamas Pharmaceuticals Inc | $6,439,000 | +137.3% | 368,166 | +137.5% | 0.92% | +115.1% |
| ALNY | Sell | Alnylam Pharmaceuticals Inc | $6,396,000 | -4.0% | 80,190 | -38.3% | 0.92% | -13.0% |
| BMY | Sell | Bristol Myers Squibb Co | $6,330,000 | -42.1% | 113,595 | -43.5% | 0.91% | -47.5% |
| LIVN | New | Livanova Plc | $6,234,000 | – | 101,854 | +100.0% | 0.90% | – |
| PTLA | Sell | Portola Pharmaceuticals Inc | $6,224,000 | +31.5% | 110,805 | -8.3% | 0.89% | +19.2% |
| KITE | Sell | Kite Pharma Inc | $6,220,000 | -28.0% | 60,000 | -45.5% | 0.89% | -34.7% |
| UHS | Buy | Universal Health Services Inc B | $6,104,000 | +40.1% | 50,000 | +42.9% | 0.88% | +27.0% |
| AMGN | Sell | Amgen Inc | $6,028,000 | -63.3% | 35,000 | -65.0% | 0.86% | -66.7% |
| RVNC | Buy | Revance Therapeutics Inc | $5,808,000 | +33.0% | 220,000 | +4.8% | 0.83% | +20.5% |
| DVAX | Sell | Dynavax Technologies Corp | $5,668,000 | -3.3% | 587,330 | -40.4% | 0.81% | -12.3% |
| AET | Sell | Aetna Inc | $5,618,000 | -15.3% | 37,000 | -28.8% | 0.81% | -23.1% |
| NBIX | Buy | Neurocrine Biosciences Inc | $5,520,000 | +50.0% | 120,000 | +41.2% | 0.79% | +36.0% |
| XNCR | Sell | Xencor Inc | $5,479,000 | -11.9% | 259,556 | -0.2% | 0.79% | -20.1% |
| NXTM | Buy | NxStage Medical Inc | $5,362,000 | +29.9% | 213,901 | +39.0% | 0.77% | +17.7% |
| FGEN | FibroGen Inc | $4,985,000 | +31.0% | 154,341 | 0.0% | 0.72% | +18.7% | |
| ANTM | Sell | Anthem Inc | $4,979,000 | -19.6% | 26,468 | -29.4% | 0.72% | -27.1% |
| IOVA | New | Iovance Biotherapeutics Inc Reg | $4,778,000 | – | 650,000 | +100.0% | 0.69% | – |
| IMMU | Buy | Immunomedics Inc | $4,676,000 | +50.7% | 529,610 | +10.4% | 0.67% | +36.7% |
| ABT | Sell | Abbott Laboratories | $4,618,000 | -9.6% | 95,000 | -17.4% | 0.66% | -18.0% |
| TMO | Sell | Thermo Fisher Scientific Inc | $4,362,000 | -29.0% | 25,000 | -37.5% | 0.63% | -35.7% |
| CAH | Sell | Cardinal Health Inc | $4,286,000 | -29.9% | 55,000 | -26.7% | 0.62% | -36.5% |
| ABC | Sell | AmerisourceBergen Corp | $4,254,000 | -23.7% | 45,000 | -28.6% | 0.61% | -30.8% |
| OMCL | Sell | Omnicell Inc | $4,061,000 | +1.4% | 94,231 | -4.4% | 0.58% | -8.0% |
| SAGE | Sell | Sage Therapeutics Inc | $3,982,000 | -22.9% | 50,000 | -31.2% | 0.57% | -30.1% |
| AERI | Sell | Aerie Pharmaceuticals Inc | $3,941,000 | +2.2% | 75,000 | -11.8% | 0.57% | -7.2% |
| EW | Sell | Edwards Lifesciences Corp | $3,902,000 | -30.9% | 33,000 | -45.0% | 0.56% | -37.4% |
| EPZM | New | Epizyme Inc | $3,807,000 | – | 252,136 | +100.0% | 0.55% | – |
| RIGL | Buy | Rigel Pharmaceuticals Inc | $3,756,000 | -11.5% | 1,375,900 | +7.3% | 0.54% | -19.8% |
| DVA | DaVita Inc | $3,562,000 | -4.7% | 55,000 | 0.0% | 0.51% | -13.7% | |
| ARRY | Buy | Array BioPharma Inc | $3,557,000 | +13.7% | 425,000 | +21.4% | 0.51% | +3.0% |
| RDUS | Radius Health Inc | $3,392,000 | +17.0% | 75,000 | 0.0% | 0.49% | +6.1% | |
| HOLX | Sell | Hologic Inc | $3,177,000 | -50.2% | 70,000 | -53.3% | 0.46% | -54.9% |
| ENDP | Sell | Endo International Plc | $3,097,000 | -31.0% | 277,303 | -31.1% | 0.44% | -37.4% |
| LH | Sell | Laboratory Corp of America Hgs | $3,083,000 | -0.3% | 20,000 | -7.2% | 0.44% | -9.6% |
| KERX | Keryx Biopharmaceuticals Inc | $3,074,000 | +17.4% | 425,111 | 0.0% | 0.44% | +6.3% | |
| MGNX | Macrogenics Inc | $3,064,000 | -5.9% | 175,000 | 0.0% | 0.44% | -14.6% | |
| CHRS | Buy | Coherus BioSciences Inc | $2,423,000 | +2.9% | 168,872 | +51.6% | 0.35% | -6.7% |
| RARE | New | Ultragenyx Pharmaceutical Inc | $2,209,000 | – | 35,573 | +100.0% | 0.32% | – |
| CMRX | Chimerix Inc | $2,180,000 | -14.6% | 400,000 | 0.0% | 0.31% | -22.5% | |
| TTPH | Tetraphase Pharmaceuticals Inc | $2,139,000 | -22.4% | 300,000 | 0.0% | 0.31% | -29.7% | |
| BIVV | Bioverativ Inc Reg S | $1,865,000 | +10.5% | 31,000 | 0.0% | 0.27% | +0.4% | |
| PODD | Insulet Corp | $1,796,000 | +19.1% | 35,000 | 0.0% | 0.26% | +7.9% | |
| HALO | Sell | Halozyme Therapeutics Inc | $1,538,000 | -30.2% | 120,000 | -29.4% | 0.22% | -36.7% |
| SUPN | Sell | Supernus Pharmaceuticals Inc | $1,293,000 | -82.0% | 30,000 | -87.0% | 0.19% | -83.7% |
| RAD | New | Rite Aid Corp | $1,033,000 | – | 350,000 | +100.0% | 0.15% | – |
| ACAD | Sell | Acadia Pharmaceuticals Inc | $837,000 | -72.9% | 30,000 | -66.7% | 0.12% | -75.5% |
| ACHN | Achillion Pharmaceuticals Inc | $762,000 | +9.0% | 166,000 | 0.0% | 0.11% | -1.8% | |
| STAA | Buy | Staar Surgical Co | $755,000 | +168.7% | 69,950 | +143.6% | 0.11% | +145.5% |
| FWP | New | Forward Pharma A/S spons ADS Level III repr 1 Share | $744,000 | – | 36,584 | +100.0% | 0.11% | – |
| RGLS | Regulus Therapeutic Inc | $585,000 | -40.2% | 593,629 | 0.0% | 0.08% | -45.8% | |
| CATB | Catabasis Pharmaceuticals Inc | $441,000 | -11.3% | 310,756 | 0.0% | 0.06% | -20.3% | |
| JPM | JPMorgan Chase & Co | $442,000 | +4.0% | 4,837 | 0.0% | 0.06% | -6.0% | |
| CNCE | Concert Pharm Inc | $420,000 | -18.1% | 30,099 | 0.0% | 0.06% | -25.9% | |
| WFC | Wells Fargo & Co | $405,000 | -0.5% | 7,305 | 0.0% | 0.06% | -9.4% | |
| XOM | Exxon Mobil Corp | $389,000 | -1.8% | 4,823 | 0.0% | 0.06% | -11.1% | |
| ADVM | Adverum Biotechnologies Inc | $385,000 | -7.5% | 154,006 | 0.0% | 0.06% | -16.7% | |
| OCUL | Ocular Therapeutix Inc | $371,000 | 0.0% | 40,000 | 0.0% | 0.05% | -10.2% | |
| ICPT | Sell | Intercept Pharmaceuticals Inc | $364,000 | -89.3% | 3,008 | -90.0% | 0.05% | -90.3% |
| OREXQ | Orexigen Therapeutics Inc | $348,000 | -15.7% | 120,000 | 0.0% | 0.05% | -23.1% | |
| HAL | Halliburton Co (Hg Co) | $330,000 | -13.2% | 7,718 | 0.0% | 0.05% | -21.7% | |
| MSFT | Microsoft Corp | $330,000 | +4.4% | 4,793 | 0.0% | 0.05% | -6.0% | |
| F | Buy | Ford Motor Co | $318,000 | +21.4% | 28,404 | +26.2% | 0.05% | +12.2% |
| BUD | Anheuser-Busch InBev SA ADR spons repr 1 Share | $310,000 | +0.6% | 2,806 | 0.0% | 0.04% | -8.2% | |
| QCOM | Qualcomm Inc | $296,000 | -3.9% | 5,368 | 0.0% | 0.04% | -14.3% | |
| IBM | IBM Corp | $272,000 | -11.7% | 1,766 | 0.0% | 0.04% | -20.4% | |
| TNDM | Tandem Diabetes Care Inc | $187,000 | -33.5% | 234,000 | 0.0% | 0.03% | -38.6% | |
| MRTX | Mirati Therapeutics Inc | $183,000 | -29.6% | 50,000 | 0.0% | 0.03% | -36.6% | |
| THLD | Threshold Pharmaceuticals | $79,000 | -31.3% | 201,537 | 0.0% | 0.01% | -38.9% | |
| OPHT | Ophthotech Corp | $61,000 | -30.7% | 23,920 | 0.0% | 0.01% | -35.7% | |
| ANTH | New | Anthera Pharmaceuticals Inc Reg | $41,000 | – | 25,000 | +100.0% | 0.01% | – |
| ANTH | Exit | Anthera Pharmaceuticals Inc | $0 | – | -200,000 | -100.0% | -0.01% | – |
| TSRO | Exit | Tesaro Inc | $0 | – | -5,000 | -100.0% | -0.12% | – |
| BDX | Exit | Becton Dickinson & Co | $0 | – | -5,000 | -100.0% | -0.14% | – |
| ISRG | Exit | Intuitive Surgical Inc | $0 | – | -4,000 | -100.0% | -0.49% | – |
| MYL | Exit | Mylan N.V. | $0 | – | -90,000 | -100.0% | -0.56% | – |
| LBIO | Exit | Lion Biotechnologies Inc | $0 | – | -650,000 | -100.0% | -0.77% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-07-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.